Monica Epstein

518 total citations · 1 hit paper
5 papers, 395 citations indexed

About

Monica Epstein is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Monica Epstein has authored 5 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 1 paper in Surgery and 1 paper in Molecular Biology. Recurrent topics in Monica Epstein's work include CAR-T cell therapy research (3 papers), Gastrointestinal Tumor Research and Treatment (1 paper) and Advancements in Semiconductor Devices and Circuit Design (1 paper). Monica Epstein is often cited by papers focused on CAR-T cell therapy research (3 papers), Gastrointestinal Tumor Research and Treatment (1 paper) and Advancements in Semiconductor Devices and Circuit Design (1 paper). Monica Epstein collaborates with scholars based in United States. Monica Epstein's co-authors include Stephanie L. Goff, Paul F. Robbins, Richard M. Sherry, Steven A. Rosenberg, Steven A. Feldman, Parisa Malekzadeh, Lori McIntyre, Mark Raffeld, Nicholas P. Restifo and Howard A. Fine and has published in prestigious journals such as Clinical Cancer Research, Annals of Surgical Oncology and Seminars in Oncology.

In The Last Decade

Monica Epstein

5 papers receiving 388 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

2019 301 citations Stephanie L. Goff, Richard A. Morgan et al. Journal of Immunotherapy profile →

Peers

Monica Epstein

ONCOL

IMMUN

BE

GENET

MB

Joseph S. Durgin United States

Xinjie Xu United States

Malvina Prapa Italy

Aesha Vakil United States

Nikita Aware Egypt

Kanwarpal Kahlon United States

Barbara S. Pender United States

Ashwini Balakrishnan United States

Siobhán Cleary Ireland

Dileshni Tilakawardane United States

Joseph S. Durgin United States

Monica Epstein

271 ×0.8

ONCOL

106 ×0.7

IMMUN

111 ×0.8

BE

43 ×0.4

GENET

119 ×1.7

MB

Citations per year, relative to Monica Epstein Monica Epstein (= 1×) peers Joseph S. Durgin

Countries citing papers authored by Monica Epstein

Since Specialization

Citations

This map shows the geographic impact of Monica Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Epstein more than expected).

Fields of papers citing papers by Monica Epstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Epstein. The network helps show where Monica Epstein may publish in the future.

Co-authorship network of co-authors of Monica Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Epstein. A scholar is included among the top collaborators of Monica Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Epstein. Monica Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Silbert, Sara, Sanna Madan, Seth M. Steinberg, et al.. (2023). A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials. Blood Advances. 7(18). 5566–5578. 2 indexed citations

2.

Green, Benjamin L., Lauren A. Gamble, Maureen Connolly, et al.. (2022). Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical Trials. Annals of Surgical Oncology. 30(3). 1852–1860. 18 indexed citations

3.

Epstein, Monica & Candis Morrison. (2022). Practical guidance for new multiple myeloma treatment regimens: A nursing perspective. Seminars in Oncology. 49(1). 103–117. 2 indexed citations

4.

Seitter, Samantha J., Richard M. Sherry, James Chih‐Hsin Yang, et al.. (2021). Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma. Clinical Cancer Research. 27(19). 5289–5298. 72 indexed citations

5.

Goff, Stephanie L., Richard A. Morgan, James C. Yang, et al.. (2019). Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma. Journal of Immunotherapy. 42(4). 126–135. 301 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact